INSERM, U1065, Equipe Biologie et Pathologie des cellules mélanocytaire: de la pigmentation cutanée au mélanome, Centre Méditerranéen de Médecine Moléculaire (C3M), Bâtiment ARCHIMED, 151 route de Saint Antoine de Ginestière, 06204 Nice cedex 3, France; UFR de Médecine, Université de Nice Sophia Antipolis, 06000 Nice, France.
Institut de Chimie de Nice UMR UNS-CNRS 7272, Université Nice Sophia Antipolis, Parc Valrose, 06108 Nice cedex 2, France.
Cancer Cell. 2016 Jun 13;29(6):805-819. doi: 10.1016/j.ccell.2016.04.013. Epub 2016 May 26.
We have discovered and developed a series of molecules (thiazole benzenesulfonamides). HA15, the lead compound of this series, displayed anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors. Our molecule displayed activity against other liquid and solid tumors. HA15 also exhibited strong efficacy in xenograft mouse models with melanoma cells either sensitive or resistant to BRAF inhibitors. Transcriptomic, proteomic, and biochemical studies identified the chaperone BiP/GRP78/HSPA5 as the specific target of HA15 and demonstrated that the interaction increases ER stress, leading to melanoma cell death by concomitant induction of autophagic and apoptotic mechanisms.
我们发现并开发了一系列分子(噻唑苯磺酰胺)。该系列的先导化合物 HA15 对所有测试的黑素瘤细胞均显示出抗癌活性,包括从患者中分离的细胞和对 BRAF 抑制剂产生耐药性的细胞。我们的分子对其他液体和实体肿瘤也具有活性。HA15 还在对 BRAF 抑制剂敏感或耐药的黑素瘤细胞的异种移植小鼠模型中表现出很强的疗效。转录组学、蛋白质组学和生化研究确定伴侣蛋白 BiP/GRP78/HSPA5 为 HA15 的特异性靶标,并表明这种相互作用会增加内质网应激,通过同时诱导自噬和凋亡机制导致黑素瘤细胞死亡。